Brief: Hester Biosciences Says Acquiring Technology For New Generation Brucella Abortus Vaccine
Sept 23 (Reuters) - Hester Biosciences Ltd HEST.NS :
* HESTER BIOSCIENCES LTD SAYS ACQUIRING TECHNOLOGY FOR A NEW
GENERATION BRUCELLA ABORTUS VACCINE
* HESTER BIOSCIENCES LTD SAYS HOPES TO LAUNCH BRUCELLA
ABORTUS
S19 DELTA PER VACCINE IN 18 MONTHS.
* HESTER BIOSCIENCES -SIGNED AGREEMENT TO GET TECHNOLOGY
FROM
ICAR-IVR
Source text for Eikon: ID:nBSE9PGX2t
Further company coverage: HEST.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hester Biosciences
See all newsIndia's Hester Biosciences jumps on quarterly profit rise
Brief: Hester Biosciences March-Quarter Consol Net Profit 159.8 Million Rupees
India's Hester Biosciences gains on plan to sell stake in Texas Lifesciences
Brief: Hester Biosciences Approves Divestment Of 43.81% Equity In Texas Lifesciences
Brief: Hester Biosciences Re-Appoints Rajiv Gandhi As CEO & MD